MacroGenics, Inc. (MGNX)

NASDAQ: MGNX · Real-Time Price · USD

1.605

-0.055 (-3.31%)

Aug 14, 2025, 2:36 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Collaborative and Other Agreements	28.99M	Log In	Log In	Log In	Log In	Upgrade
Collaborative and Other Agreements Growth	-75.70%	Log In	Log In	Log In	Log In	Upgrade
Monoclonal Antibody-based Therapeutics	17.94M	Log In	Log In	Log In	Log In	Upgrade
Monoclonal Antibody-based Therapeutics Growth	7.25%	Log In	Log In	Log In	Log In	Upgrade
Contract Manufacturing	9.83M	Log In	Log In	Log In	Log In	Upgrade
Contract Manufacturing Growth	-29.70%	Log In	Log In	Log In	Log In	Upgrade
Government Agreements	1.56M	Log In	Log In	Log In	Log In	Upgrade
Government Agreements Growth	-19.08%	Log In	Log In	Log In	Log In	Upgrade
Royalty	431.00K	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	58.75M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-61.33%	Log In	Log In	Log In	Log In	Upgrade